CliffBio
small molecule

BUTORPHANOL TARTRATE

BUTORPHANOL TARTRATE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameBUTORPHANOL TARTRATE
Active ingredientBUTORPHANOL TARTRATE
Strength2MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalOctober 2001
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.